ACUTE MYELOID LEUKEMIA, REFRACTORY
Clinical trials for ACUTE MYELOID LEUKEMIA, REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy targets tough childhood leukemia
Disease control TerminatedThis early-stage study tested a new treatment for children and young adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in a lab to recognize and attack leukemia cells. The …
Matched conditions: ACUTE MYELOID LEUKEMIA, REFRACTORY
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Immune cell infusion trial for leukemia halted early
Disease control TerminatedThis study tested a treatment for adults with acute myeloid leukemia that returned or didn't respond to standard therapy. Participants received donor natural killer (NK) cells plus a drug called IL-2 to boost the immune system. The trial was stopped early after enrolling 9 people…
Matched conditions: ACUTE MYELOID LEUKEMIA, REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC